公司资料
Ibio Inc 股价、新闻与催化剂
- 股票代码:
- IBIO
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.45 USD (+1.40%)
收盘价
最后更新: 2026年8月17日
87.4M USD
市值
股价为何变动
As of Aug 17, 2026, IBIO closed up 1.40% at $1.45. No new same-company headline was identified in the current news window.
公司概览
AI-Enabled Antibody Discovery
iBio develops antibodies using computational discovery and engineering platforms designed to improve target selection and molecular properties.
IBIO-600
IBIO-600 is a long-acting anti-myostatin antibody intended to preserve lean mass and improve body composition during obesity treatment.
Cardiopulmonary Expansion
The pipeline also includes a bispecific antibody program for pulmonary hypertension associated with heart failure with preserved ejection fraction.
未来催化剂
- iBio has received Australian regulatory clearance to initiate a first-in-human Phase 1 study of IBIO-600.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。